Michael Stewart Lee insider trades

Open-market stock purchases and sales by Michael Stewart Lee, Director at Fate Therapeutics Inc, from SEC Form 4 filings since Jul 31, 2018.

Recent trades

DateStockTradeValue
Jun 12, 2026FATE Fate Therapeutics IncBought (not open market)—

Companies traded

  • FATE Fate Therapeutics Inc: other filings, last Jun 12, 2026
  • IGMS IGM Biosciences, Inc: other filings, last Aug 14, 2025
  • STTK Shattuck Labs, Inc: other filings, last Jul 14, 2025

Get free alerts when Michael Stewart Lee files a new trade →